Skip Navigation



NDT Advance Access published online on December 18, 2007

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm700
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/4/1370    most recent
gfm700v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by David, S.
Right arrow Articles by Fliser, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by David, S.
Right arrow Articles by Fliser, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Diagnostic Value of N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP) for Left Ventricular Dysfunction in Patients with Chronic Kidney Disease Stage 5 on Haemodialysis

Sascha David1, Philipp Kümpers1, Vega Seidler1, Frank Biertz2, Hermann Haller1 and Danilo Fliser1

1 Department of Nephrology, Medical School Hannover, Germany 2 Institute of Biometry and Statistics, Medical School Hannover, Germany

Correspondence and offprint requests to: Sascha David, Department of Nephrology, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Tel: ( +49)-511-532-6319; Fax: ( +49)-511-55-23-66; E-mail: david.sascha{at}mh-hannover.de



  Abstract

Background. Natriuretic peptides such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) have become increasingly important in diagnosing left ventricular dysfunction (LVD), however, in patients with chronic kidney disease (CKD), their use is confounded by concomitant volume overload and reduced renal excretion. We hypothesized that a serum NT-proBNP cut-off value adjusted for patients with CKD could serve as a biochemical marker to detect LVD in patients on haemodialysis treatment regardless of chronic fluid overload.

Methods. We assessed LV function using trans-thoracic echocardiography and indices of hydration status such as extracellular water (ECW) using bioelectrical impedance analysis (BIA) in 62 stable patients on maintenance haemodialysis. NT-proBNP cutoff values for LVD with different specificities and sensitivities were calculated by ROC curves.

Results. We found a significant inverse correlation between LV ejection fraction (EF) and NT-proBNP levels (r = –0.77, P < 0.0001). In the multivariate regression analysis NT-proBNP was the only independent predictor of EF (r = 0.699, P < 0.0001). NT-proBNP levels were significantly higher (P < 0.0001) in patients with LVD (n = 15; 32 760 ± 6605 ng/L) compared to those without LVD (n = 47; 2835 ± 428 ng/L). An NT-proBNP cut-off value of 7168 ng/L resulted in 90% specificity and 79% sensitivity for the presence of LVD, i.e. an EF <45% (AUCROC: 0.95 ± 0.03, P < 0.0001). Furthermore, in patients with LVD we found a significant relationship between serum NT-proBNP and markers of fluid overload such as the ECW/body weight ratio (P < 0.0001) and the grade of peripheral oedema (P = 0.007), but not in patients without LVD.

Conclusion. A serum NT-proBNP cut-off value of ≥7200 ng/L discriminates CKD stage 5 patients without LVD from those with LVD. In those patients with LVD, persistent post-dialytic volume overload correlates with elevated NT-proBNP levels.

Keywords: bioelectrical impedance analysis (BIA); chronic kidney disease (CKD); left ventricular dysfunction (LVD); maintenance haemodialysis (HD); N-terminal pro-B-type natriuretic peptide (NT-proBNP)

Received for publication: 9. 7.07
Accepted in revised form: 10. 9.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
L. H. Jacobs, J. J. van de Kerkhof, A. M. Mingels, V. L. Passos, V. W. Kleijnen, A. H. Mazairac, F. M. van der Sande, W. K. Wodzig, C. J. Konings, K. M. Leunissen, et al.
Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study
Nephrol. Dial. Transplant., August 19, 2009; (2009) gfp417v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. David, P. Kumpers, G. M. Eisenbach, H. Haller, and J. T. Kielstein
Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2232 - 2240.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Y.-M. Wang, C. W.-K. Lam, M. Wang, I. H.-S. Chan, S.-F. Lui, Y. Zhang, and J. E. Sanderson
Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1962 - 1969.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.